nav-left cat-right
cat-right

Insight Pharma Reports Announces Digital PCR Techn...

Digital PCR Technology Report: An Insight to Vendors, Costs & the End User Community NEEDHAM, MASS. – November 1, 2013 – Cambridge Healthtech Institute’s Insight Pharma Reports announces Digital PCR Technology Report: An Insight to Vendors, Costs & the End User Community. The newly released Insight Pharma Report is about the digital PCR technologies that have surfaced in the market. Digital PCR is a new...

Macrocycles: Discovery, Development & Technol...

Insight Pharma Report announces its newest report with expanded focus, coverage and primary data! NEEDHAM, MASSACHUSETTS, UNITED STATES, November 11, 2013 — Cambridge Healthtech Institute’s Insight Pharma Reports announces Macrocycles: Discovery, Development & Technologies. This report covers background material including a more in depth analysis of what macrocycles are and the pharmacokinetic properties...

5 Ways Technology Is Changing Personalized Medicin...

By Thomas Heydler October 18, 2013 | In today’s doctor’s office, when a physician diagnoses a patient, a number of tests are consulted and the best possible course of treatment is prescribed. Unfortunately there is often limited data that allows the doctor to tailor and customize treatment specifically to a patient’s biology and lifestyle. But there are five ways technology will change that over the next decade,...

What You Shouldn’t be Doing for Your Health

While the American population is not as healthy as it should be right now, we’re at a wonderful point in history, whereby there are cures and treatments for the most common diseases and conditions. Regardless of age, gender or race, there are many maladies to which you may be prone, and some of them may be hereditary and/or preventable. Various types of cancer, heart disease, diabetes, obesity and blood pressure issues,...

PROTEROS ANNOUNCES APPOINTMENT OF NEW CHIEF FINANC...

Martinsried, Germany, October 11, 2012. Proteros biostructures GmbH (“Proteros”) today announced the appointment of Mr. Arnd Christ as Chief Financial Officer (CFO) as of 16th of November. Arnd Christ has more than 12 years of international experience as a CFO in the biotechnology industry, with responsibilities in finance, operations, legal affairs and investor relations. He has successfully conducted a number of...

Firms Flock to Epic’s CTC Platform

Cancer diagnostics specialist Epic Sciences reported signing collaborations with six pharma companies centered on the application of its circulating tumor cell (CTC) capture and analysis technology to identify biomarkers that can serve as the basis of companion diagnostics. The collaborations involve 12 clinical trials that are part of 40 distinct projects measuring 18 different markers. Epic was spun out of the...
Page 2 of 1612345...10...Last »